D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 15.3 CNY -5.9% Market Closed
Market Cap: 17.4B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
DaShenLin Pharmaceutical Group Co Ltd

Wall Street analysts forecast DaShenLin Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DaShenLin Pharmaceutical Group Co Ltd is 25.24 CNY with a low forecast of 12.12 CNY and a high forecast of 35.7 CNY.

Lowest
Price Target
12.12 CNY
21% Downside
Average
Price Target
25.24 CNY
65% Upside
Highest
Price Target
35.7 CNY
133% Upside
DaShenLin Pharmaceutical Group Co Ltd Competitors:
Price Targets
FRAGUAB
Corporativo Fragua SAB de CV
94% Upside
3349
Cosmos Pharmaceutical Corp
25% Upside
RDC
Redcare Pharmacy NV
11% Upside
DMVF3
d1000 Varejo Farma Participacoes SA
11% Upside
314
Sipai Health Technology Co, Ltd
122% Upside
3549
Kusuri No Aoki Holdings Co Ltd
18% Upside
MEDPLUS
MedPlus Health Services Ltd
27% Upside
4164
Al Nahdi Medical Company SCJSC
15% Upside

Revenue
Forecast

Revenue Estimate
DaShenLin Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for DaShenLin Pharmaceutical Group Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 18%.

21%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
DaShenLin Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for DaShenLin Pharmaceutical Group Co Ltd's operating income is 16%. The projected CAGR for the next 3 years is 16%.

16%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
DaShenLin Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for DaShenLin Pharmaceutical Group Co Ltd's net income is 14%. The projected CAGR for the next 3 years is 18%.

14%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DaShenLin Pharmaceutical Group Co Ltd's stock price target?
Price Target
25.24 CNY

According to Wall Street analysts, the average 1-year price target for DaShenLin Pharmaceutical Group Co Ltd is 25.24 CNY with a low forecast of 12.12 CNY and a high forecast of 35.7 CNY.

What is DaShenLin Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for DaShenLin Pharmaceutical Group Co Ltd's revenue is 21%. The projected CAGR for the next 3 years is 18%.

What is DaShenLin Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for DaShenLin Pharmaceutical Group Co Ltd's operating income is 16%. The projected CAGR for the next 3 years is 16%.

What is DaShenLin Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for DaShenLin Pharmaceutical Group Co Ltd's net income is 14%. The projected CAGR for the next 3 years is 18%.

Back to Top